Navigation Links
Comments on The Nobel Prize Assembly's Response to the Lawsuit Filed by Life Scientist, Dr. Rongxiang Xu
Date:3/5/2013

LOS ANGELES, March 5, 2013 /PRNewswire/ -- The Nobel Assembly at Karolinska Institutet, The Nobel Assembly responded to Dr. Rongxiang Xu's defamation lawsuit on Feb. 22, 2013 by filing a notice to remove the lawsuit from State Court to Federal Court, in Los Angeles.

(Photo: http://photos.prnewswire.com/prnh/20130305/LA71370)

According to attorneys for Dr. Xu, the transfer of the case to Federal Court would not affect the substantive nature of the lawsuit but is merely a procedural strategic move by the Defendant.  Dr. Xu's lawsuit was filed in December 2012 in connection with the Nobel Assembly's awarding of the 2012 Nobel Prize in Physiology or Medicine.

According to Dr. Xu, the lawsuit was not intended to tarnish the reputation of the Nobel Assembly, but it was filed, in part, to clarify a vital misunderstanding concerning the "conversion of human somatic cells into stem cells and regeneration of physiological tissues." Through his own research on human regenerative science during the past several decades, Dr. Xu claims to have discovered and proved that this conversion is an innate ability found in our cells, a natural phenomenon that he says he has demonstrated through successful clinical applications time and time again. According to his claims, the cellular conversion does not require the engineering of man-made cells, which is the approach that was taken by the recipients of the 2012 Nobel Prize.

In his complaint, Dr. Xu provides examples of the results of some of his clinical applications, including an array of patents and publications that detail and verify the "in situ conversion of human somatic cells into stem cells followed by in situ regeneration of physiological tissues." These applications include:

  • in situ skin regeneration for severe burns
  • regenerative restoration of severed fingers
  • regenerative elimination of cutaneous scars
  • in situ regeneration of degenerative atrophic gastrointestinal villi back to normal structure     of young status

Based on his results, Dr. Xu insists that the "conversion of human somatic cells into stem cells and regeneration of physiological tissues" is an innate human ability, not one that should be created by man-made cells. But since the Nobel Assembly awarded two scientists for the latter approach, for artificially converting somatic cells into a state of self-proclaimed "pluripotency" through nuclear transfer and cellular reprogramming, Dr. Xu believes that the Nobel Assembly had a duty to accurately describe the Laureates' works and acknowledge Dr. Xu's findings that were demonstrated and proved years earlier.  Dr. Xu believes that the Nobel Assembly's description of the Laureates' work was misleading and it disparaged and undermined his scientific achievements and professional reputation, which is what led to the filing of his complaint.

Dr.  Xu strongly believes that the public should be made aware of the critical distinction between having the "conversion of human somatic cells into stem cells and regeneration of physiological tissues" as an innate human ability versus one that is produced by artificial, man-made cells. The lawsuit is not only an action taken to protect his science, but also one that he hopes to edify the public about the responsibility in life science research regarding facticity of knowledge. After all, the Nobel Prize in Physiology or Medicine represents the mainstream of life science research and influences directly the safety of human lives, which is of the most importance.

About  Rongxiang Xu

Dr. Xu is the founder of human body regenerative restoration science. He filed a lawsuit in December 2012 against The Nobel Assembly at Karolinska Institutet, a body which awards the Nobel Prize in Physiology or Medicine. The suit was filed in Superior Court of the State of California, Orange County Central Justice Center and cites Libel and unfair competition. On October 8, 2012, The Nobel Prize in Physiology or Medicine 2012 was awarded jointly to Sir John B. Gurdon and Shinya Yamanaka "for the discovery that mature cells can be reprogrammed to become pluripotent. Dr. Xu alleges that some of the statements made by the Nobel Assembly were false as he was the scientist who made the discovery a decade earlier.

http://www.mebo-international.com/about-us/timeline

Please find an example of the regenerative restoration science below. For additional information contact:
Jane Westgate : 336-209-9276, Jane@westgatecom.com, or
Cheryl Riley : 703-683-1798, cherylrileypr@comcast.net.


'/>"/>
SOURCE Mebo International
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MetroStar Home Health COO Comments on the Effect of the Newly Instituted Competitive Bidding Program from the Centers for Medicare & Medicaid Services on Beneficiaries
2. Medbox, Inc. Comments on California Supreme Court Decision
3. Novation Submits Comments to FDA in support of Unique Device Identification Rule
4. Questcor Comments on Insurance Policy Bulletin
5. NxStage Submits Formal Comments to CMS to Improve Patient Access to Life-changing More Frequent Home Hemodialysis Therapy
6. Purdue Pharma L.P. Comments on FDA Announcement on REMS for Extended-Release and Long-Acting Opioid Analgesics
7. World Renowned Scientist, Dr. Rongxiang Xu Speaks Out About Nobel Assembly Statement Claiming They Have Not Heard Of Him
8. Submit Questions to Nobel Laureates and Other Experts about Genetics and Society
9. Nobel Prize Winner Bruce Beutler joins Sound Pharmaceuticals
10. The Galien Foundation Announces Roster of Luminary Presenters for Third Galien Forum; Program Highlights Include CEO Panel, Panel on Alzheimers Disease Innovation, Nobel Laureate Elie Wiesel
11. $1,000,000 Global B.R.A.I.N. Prize Seeks Applicants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... On Thursday, Feb. 11, 2016, surgeons at ... North Austin Medical Center successfully completed the first robotic ... Surgical System with Trumpf Medical,s advanced operating table, ... , M.D., colorectal surgeon at the Texas Institute for ... Motion technology, which seamlessly combines the da Vinci Xi ...
(Date:2/12/2016)... 12, 2016  Eli Lilly and Company (NYSE: LLY ... Alimta® (pemetrexed disodium) vitamin regimen patent would not presently be ... France , Italy and ... product only with dextrose solution.  --> ... Court of Appeal held that Lilly,s patent would be indirectly ...
(Date:2/12/2016)... Ga. , Feb. 12 2016  OMS Supply, ... dental and medical practitioners, announced today the recent launching ... offers visitors a variety of features that enhance the ... oral surgery supplies. --> ... is a fairly new company that started in early ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... February 13, 2016 , ... ... top Clinical Data Management Solution Providers list for its expertise in eClinical Solutions. ... domain expertise to serve the technology needs of global clients. DDi provides smarter ...
(Date:2/12/2016)... TX (PRWEB) , ... February 12, 2016 , ... Mystic ... as expressed in Blue SKies Buddha, the biography of Rama - Dr. Frederick Lenz. ... a love story, the love of a Buddhist teacher for teaching and helping others. ...
(Date:2/12/2016)... WA, and Washington, DC (PRWEB) , ... ... ... PATH and the Siemens Foundation today announced a new initiative—the Siemens Foundation-PATH ... for low-resource settings. The partnership will recruit top students from U.S. universities ...
(Date:2/12/2016)... ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future , Feb. ... , As Winston Churchill said, “Those who don’t learn from history are doomed to repeat ... when they come knocking this year. But that takes time. , Take a close ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Each year, ... will be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 physical ... see new therapy products in action, learn more about their chosen field and network ...
Breaking Medicine News(10 mins):